Order Entry
United States
ContactUsLinkComponent
SensoLyte® 520 MMP Profiling Kit (Fluorimetric), AnaSpec
SensoLyte® 520 MMP Profiling Kit (Fluorimetric), AnaSpec
Catalog # 103010-164
Supplier:  Anaspec Inc
CAS Number:  
SensoLyte® 520 MMP Profiling Kit (Fluorimetric), AnaSpec
Catalog # 103010-164
Supplier:  Anaspec Inc
Supplier Number:  AS-71136
CAS Number:  
Restricted Products: To process your orders without delay, please provide the required business documentation to purchase this product.

To order chemicals, medical devices, or other restricted products please provide ID that includes your business name & shipping address via email [email protected] or fax 484.881.5997 referencing your VWR account number. Acceptable forms of ID are:

  • • State issued document with your organization's Federal Tax ID Number
  • • State issued document with your organization's Resale Tax ID Number
  • • City or County issued Business License
  • • State Department of Health Services License
  • • Any other ID issued by the State that includes the business name & address

* ATTN: California Customers may require additional documentation as part of the CA Health & Safety Code. Products that fall under this regulation will be placed on a mandatory 21-day hold after documentation is received. Avantor will not lift restrictions for residential shipping addresses.

Specifications

  • Size:
    Two 96-well Plate
  • Cat. No.:
    103010-164
  • Storage temperature:
    –20 °C
  • Includes:
    Two 96-well plates, essential components and detailed protocol and references
  • Supplier no.:
    AS-71136

Specifications

About this item

Matrix metalloproteinases (MMPs) belong to a family of secreted or membrane-associated proteins capable of digesting extracellular matrix components

SensoLyte® 520 MMP Profiling Kit contains a series of well-designed FRET peptide substrates for use as fluorogenic indicators to assay MMP protease activities. It provides the best solution for profiling MMPs or MMP inhibitors.

They are involved in diseases such as cancer, arthritis, asthma, angiogenesis, alopecia and metastasis. They are also identified as drug-screening targets.